Issue 4/2013
Content (8 Articles)
Lung cancer stem cells: a biological and clinical perspective
Ana Koren, Helena Motaln, Tanja Cufer
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
Nir Peled, Murry W. Wynes, Norihiko Ikeda, Tatsuo Ohira, Koichi Yoshida, Jin Qian, Maya Ilouze, Ronen Brenner, Yasufumi Kato, Celine Mascaux, Fred R. Hirsch
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation
Macarena Perán, Juan Antonio Marchal, Maria A. García, Julian Kenyon, David Tosh
Biofunctional characteristics of in situ and invasive breast carcinoma
Sara Bravaccini, Anna Maria Granato, Laura Medri, Flavia Foca, Fabio Falcini, Wainer Zoli, Monica Ricci, Giuseppe Lanzanova, Nestory Masalu, Luigi Serra, Federico Buggi, Secondo Folli, Rosella Silvestrini, Dino Amadori
Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor
Sang-Woo Lim, Hye-Ran Kim, Hwan-Young Kim, Jung-Wook Huh, Young-Jin Kim, Jong-Hee Shin, Soon-Pal Suh, Dong-Wook Ryang, Hyeong-Rok Kim, Myung-Geun Shin
Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas
Yanjie You, Wenjun Yang, Zhizhong Wang, Huimin Zhu, Haijun Li, Canfeng Lin, Yonggang Ran
Analysis of expression of membrane-bound tumor markers in ductal carcinoma in situ of the breast: paving the way for molecular imaging
Jeroen F. Vermeulen, Elsken van der Wall, Arjen J. Witkamp, Paul J. van Diest
Visualising and quantifying angiogenesis in metastatic colorectal cancer
Torben Frøstrup Hansen, Boye Schnack Nielsen, Anders Jakobsen, Flemming Brandt Sørensen